Purchase Order HHSN275201700425P

The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $532,500 purchase order to Pearson Pharma Partners of Thousand Oaks, California for Drug Metabolism and Pharmacokinetics (DMPK) Consulting Support Services. The contract is set aside for small businesses and will provide senior-level DMPK consultants to advise the Blueprint Neurotherapeutics Program and other NIH neuroscience initiatives on study design,...

This is a $724,461 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract is for the Cardiovascular-Kidney-Metabolic (CKM) Syndrome Patient-Reported Outcome (PRO) Burden Measure project, referenced as FDABAA-24-00123, with a performance period ending on November 15, 2026. PPD Development LP has significant experience supporting federal...

This is a firm fixed price BPA call contract awarded by the National Institutes of Health (NIH) Clinical Center to Propharma Group LLC, doing business as Acadeus, for $115,000.00. The contract is part of a larger $15 million Blanket Purchase Agreement for expert consultant services at the NIH Clinical Center, running through March 2025. Propharma Group is a for-profit Research Consulting Organization specializing in expert consulting services to improve patient health and safety across product...

This is a $4,130 firm-fixed-price purchase order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Pharmaron (Exton) Lab Services LLC, doing business as Absorption Systems. The contract is for an in-vivo pharmacokinetic (PK) study to determine the optimal formulation for dosing cytochrome P inhibitors and analyzing their concentrations in mouse plasma. This contract is not designated as a small business set-aside. Pharmaron is a global...

The federal contract award is for PROPHARMA GROUP, LLC, a Research Consulting Organization (RCO) doing business as Acadeus. The contract, valued at $150,000.00, was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency, under a Blanket Purchase Agreement (BPA) Call contract type. The award is for expert consulting services to support the agency's reorganization, quality unit operations, and investigational drug management. Propharma Group LLC is the...

The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $684,700 labor-hour contract to Allucent Government Services (Us) LLC, a for-profit contract research organization, to provide subject matter expert consulting services for drug metabolism pharmacokinetics (DMPK). The contract has an ultimate completion date of June 30, 2025 and was awarded on July 1, 2022 without any set-aside designation. Allucent is a key partner for the U.S. federal government, holding several...

This is a $1,299,218 definitive contract awarded by the Food and Drug Administration (FDA) to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract is for "BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS" and has a completion date of February 2, 2026. The contract is a Time and Materials type with no set-aside designation. As a CRO, PPD...

This firm fixed-price purchase order contract, valued at $54,000.00, was awarded by the National Center for Advancing Translational Sciences (NCATS), a division of the National Institutes of Health (NIH), to Pharmaron, Inc. Pharmaron is a minority-owned, for-profit Subcontinent Asian (Asian-Indian) American contract research organization that specializes in preclinical drug discovery and development services. The contract is for testing 20 small molecule compounds in rat pharmacokinetic...

This federal contract award is for regulatory consulting assistance and research and development for clinical studies in the Blueprint MedTech program, which is managed by the National Institute on Drug Abuse (NIDA), a civilian agency. The award was made to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract has a period of performance from September 15, 2023 to September 14, 2024, with a ceiling value of $64,107.00. This...

This federal contract award was made by the Food and Drug Administration (FDA) to Altasciences Clinical Kansas Inc., a contract research organization specializing in early phase drug development services. The $1,293,840.24 firm fixed price definitive contract is for a project on the pharmacokinetics study of an opioid drug product following insufflation of milled drug products. The contract has an ultimate completion date of September 30, 2019 and was awarded on September 17, 2015. No...